0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

What Is Really New in Progressive Muscle Atrophy?—Reply

Renske M. Van den Berg-Vos, MD, PhD
Arch Neurol. 2009;66(11):1427-1429. doi:10.1001/archneurol.2009.255.
Text Size: A A A
Published online

Extract

In reply

We thank de Carvalho and Swash for their valuable comments on our study.1 In their prospective study of 10 patients with PMA with relatively short mean disease durations (maximum 14 months), they describe a follow-up of 12 months with variable disease progression and with development of respiratory involvement in 4 patients and death due to respiratory failure in 2.2 Axial-onset disease especially was more likely to progress to respiratory involvement, which can be explained by the adjacent location of anterior horn cells innervating axial and respiratory muscles. In our group of 32 patients with a mean follow-up of 6 years, only 1 patient had a bulbar onset with axial weakness and a progressive disease course with the development of respiratory involvement and upper motor neuron signs such that the diagnosis was changed to ALS. However, these 2 groups cannot be easily compared because of the differences in disease duration. In a previously published study, we described 37 patients with PMA3 with a median disease duration of 15 months, comparable with the study by de Carvalho and Swash.2 Although none of the 37 patients had a bulbar or axial onset, 10 had bulbar signs and symptoms at inclusion, and all died owing to respiratory failure during follow-up. The median survival duration after initial weakness was 56 months in the group, which is comparable with previous studies of ALS. The variable disease progression in groups of patients with relatively short disease duration can thus be explained by the heterogeneity of the groups, consisting of both PMA, having a relatively bad prognosis, and segmental forms with no or minimal progression.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

November 1, 2009
Renske M. Van den Berg-Vos, MD, PhD
Arch Neurol. 2009;66(11):1427-1429. doi:10.1001/archneurol.2009.255.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

20 Views
3 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Is This Adult Patient Malnourished?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
2. Muscle Wasting

brightcove.createExperiences();